Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Evaluation of Treosulfan Versus Melphalan Conditioning Followed by PTCy in Patients With AML and MDS Undergoing Allogeneic Transplantation

NCT07025824 is registered in ClinicalTrials.gov with Technische Universität Dresden as lead sponsor.

NCT NCT07025824
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07025824 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Evaluation of Treosulfan Versus Melphalan Conditioning Followed by PTCy in Patients With AML and MDS Undergoing Allogeneic Transplantation
Lead sponsor
Technische Universität Dresden
Phase
Phase 2
Overall status
Recruiting
Start date
January 21, 2026
Completion date
September 30, 2029
Enrollment
220 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

aml - acute myeloid leukemia, mds (myelodysplastic syndrome)